{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:06:29Z","timestamp":1790539589831,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":250,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91849130"],"award-info":[{"award-number":["91849130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1074\/jbc.ra119.010809","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T21:44:11Z","timestamp":1573681451000},"page":"20164-20176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Dual-specificity tyrosine phosphorylation-regulated kinase 1A ameliorates insulin resistance in neurons by up-regulating IRS-1 expression"],"prefix":"10.1016","volume":"294","author":[{"given":"Shijiao","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.010809_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract"},{"key":"10.1074\/jbc.RA119.010809_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease: is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.RA119.010809_bib3","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig"},{"key":"10.1074\/jbc.RA119.010809_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","article-title":"High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice","volume":"67","author":"Arnold","year":"2014","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA119.010809_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-160640","article-title":"Mitochondrial abnormalities and synaptic loss underlie memory deficits seen in mouse models of obesity and Alzheimer's disease","volume":"55","author":"Martins","year":"2017","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.RA119.010809_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol. Rev"},{"key":"10.1074\/jbc.RA119.010809_bib7","first-page":"168","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev"},{"key":"10.1074\/jbc.RA119.010809_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007917","article-title":"Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease","volume":"4","author":"Ke","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010809_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol"},{"key":"10.1074\/jbc.RA119.010809_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc13-1672","article-title":"Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes","volume":"37","author":"Novak","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1074\/jbc.RA119.010809_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates \u03b2-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1074\/jbc.RA119.010809_bib12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2337\/db14-1000","article-title":"Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes","volume":"64","author":"Zhang","year":"2015","journal-title":"Diabetes"},{"key":"10.1074\/jbc.RA119.010809_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02896897","article-title":"Insulin and IGF-I stimulate phosphorylation of their respective receptors in intact neuronal and glial cells in primary culture","volume":"1","author":"Shemer","year":"1989","journal-title":"J. Mol. Neurosci"},{"key":"10.1074\/jbc.RA119.010809_bib14","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"\u03b2-Amyloid oligomers induce phosphorylation of Tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by \u03c9-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA119.010809_bib15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/MCB.22.4.1016-1026.2002","article-title":"Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1","volume":"22","author":"Zhande","year":"2002","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.RA119.010809_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1210\/en.2009-0838","article-title":"Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation","volume":"151","author":"Mayer","year":"2010","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.RA119.010809_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.RA119.010809_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2017.03.032","article-title":"A novel dual GLP-1\/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model","volume":"327","author":"Shi","year":"2017","journal-title":"Behav. Brain Res"},{"key":"10.1074\/jbc.RA119.010809_bib19","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00018-009-0123-2","article-title":"Function and regulation of Dyrk1A: towards understanding Down syndrome","volume":"66","author":"Park","year":"2009","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/jbc.RA119.010809_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","article-title":"The role of DYRK1A in neurodegenerative diseases","volume":"278","author":"Wegiel","year":"2011","journal-title":"FEBS J"},{"key":"10.1074\/jbc.RA119.010809_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2015.03.004","article-title":"DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications","volume":"151","author":"Abbassi","year":"2015","journal-title":"Pharmacol. Therap"},{"key":"10.1074\/jbc.RA119.010809_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1742-4658.2010.07954.x","article-title":"MNB\/DYRK1A as a multiple regulator of neuronal development","volume":"278","author":"Tejedor","year":"2011","journal-title":"FEBS J"},{"key":"10.1074\/jbc.RA119.010809_bib23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA119.010809_bib24","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau: a functional link between Down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010809_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-4159.2010.06769.x","article-title":"Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease","volume":"115","author":"Ryu","year":"2010","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA119.010809_bib26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/acel.12648","article-title":"Dyrk1 inhibition improves Alzheimer's disease-like pathology","volume":"16","author":"Branca","year":"2017","journal-title":"Aging Cell"},{"key":"10.1074\/jbc.RA119.010809_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in Down syndrome","volume":"10","author":"Duchon","year":"2016","journal-title":"Front. Behav. Neurosci"},{"key":"10.1074\/jbc.RA119.010809_bib28","article-title":"Dual-specificity tyrosine-phosphorylation regulated kinase 1A gene transcription is regulated by myocyte enhancer factor 2D","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.010809_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12867-015-0043-7","article-title":"RE1 silencing transcription factor (REST) negatively regulates ALL1-fused from chromosome 1q (AF1q) gene transcription","volume":"16","author":"Hu","year":"2015","journal-title":"BMC Mol. Biol"},{"key":"10.1074\/jbc.RA119.010809_bib30","doi-asserted-by":"crossref","first-page":"26399","DOI":"10.1074\/jbc.M116.717553","article-title":"E3 Ligase SCF\u03b2TrCP-induced DYRK1A protein degradation is essential for cell cycle progression in HEK293 cells","volume":"291","author":"Liu","year":"2016","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010809_bib31","article-title":"NFATc1 phosphorylation by DYRK1A increases its protein stability","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010809_bib32","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1074\/jbc.272.3.1929","article-title":"Expression of neuronal traits in pancreatic \u03b2 cells: implication of neuron-restrictive silencing factor\/repressor element silencing transcription factor, a neuron-restrictive silencer","volume":"272","author":"Atouf","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010809_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s001250050706","article-title":"The pancreatic \u03b2-cell as a fuel sensor: an electrophysiologist's viewpoint","volume":"40","author":"Rorsman","year":"1997","journal-title":"Diabetologia"},{"key":"10.1074\/jbc.RA119.010809_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9372","article-title":"Inhibition of DYRK1A and GSK3B induces human \u03b2-cell proliferation","volume":"6","author":"Shen","year":"2015","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA119.010809_bib35","first-page":"638","article-title":"Combined inhibition of DYRK1A, SMAD, and Trithorax pathways synergizes to induce robust replication in adult human \u03b2 cells","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA119.010809_bib36","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db15-1127","article-title":"Inhibition of DYRK1A stimulates human \u03b2-cell proliferation","volume":"65","author":"Dirice","year":"2016","journal-title":"Diabetes"},{"key":"10.1074\/jbc.RA119.010809_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic \u03b2 cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA119.010809_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","article-title":"Activation, regulation, and inhibition of DYRK1A","volume":"278","author":"Becker","year":"2011","journal-title":"FEBS J"},{"key":"10.1074\/jbc.RA119.010809_bib39","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.1038\/sj.onc.1208104","article-title":"Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependent mechanism","volume":"23","author":"del Rinc\u00f3n","year":"2004","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA119.010809_bib40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diabetes.48.7.1359","article-title":"Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway","volume":"48","author":"Sun","year":"1999","journal-title":"Diabetes"},{"key":"10.1074\/jbc.RA119.010809_bib41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.molcel.2008.03.009","article-title":"The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation","volume":"30","author":"Xu","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.010809_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(02)04069-6","article-title":"Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system","volume":"964","author":"Mart\u00ed","year":"2003","journal-title":"Brain Res"},{"key":"10.1074\/jbc.RA119.010809_bib43","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/jcp.24019","article-title":"Nuclear IRS-1 and cancer","volume":"227","author":"Reiss","year":"2012","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/jbc.RA119.010809_bib44","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS-1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"10.1074\/jbc.RA119.010809_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1096\/fj.14-262048","article-title":"Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease","volume":"29","author":"Kapogiannis","year":"2015","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA119.010809_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/BJ20051194","article-title":"A novel regulation of IRS-1 (insulin receptor substrate-1) expression following short term insulin administration","volume":"392","author":"Ruiz-Alcaraz","year":"2005","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA119.010809_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-62703-068-7_4","article-title":"Diabetes in mice with monogenic obesity: the db\/db mouse and its use in the study of cardiac consequences","volume":"933","author":"Belke","year":"2012","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.RA119.010809_bib48","first-page":"1864","article-title":"Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance","volume":"15","author":"Sykiotis","year":"2001","journal-title":"Mol. Endocrinol"},{"key":"10.1074\/jbc.RA119.010809_bib49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbalip.2016.12.008","article-title":"Cyanidin-3-O-glucoside ameliorates palmitate-induced insulin resistance by modulating IRS-1 phosphorylation and release of endothelial derived vasoactive factors","volume":"1862","author":"Fratantonio","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1074\/jbc.RA119.010809_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18081-8","article-title":"Inhibition of C1-Ten PTPase activity reduces insulin resistance through IRS-1 and AMPK pathways","volume":"7","author":"Jeong","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.010809_bib51","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4161\/cc.29250","article-title":"Dyrk1A induces pancreatic \u03b2 cell mass expansion and improves glucose tolerance","volume":"13","author":"Rachdi","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.RA119.010809_bib52","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00125-014-3174-3","article-title":"Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic \u03b2 cell mass","volume":"57","author":"Rachdi","year":"2014","journal-title":"Diabetologia"},{"key":"10.1074\/jbc.RA119.010809_bib53","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1074\/jbc.M110.177519","article-title":"Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation","volume":"286","author":"Sun","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010809_bib54","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1096\/fj.09-134296","article-title":"Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways","volume":"23","author":"Liu","year":"2009","journal-title":"FASEB J"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820300338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820300338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.010809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:29:56Z","timestamp":1695421796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820300338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":54,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0021925820300338"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.010809","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A ameliorates insulin resistance in neurons by up-regulating IRS-1 expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.010809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Tian et al.","name":"copyright","label":"Copyright"}]}}